F-18-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma

Autor: Alfred O. Ankrah, Thabo Lengana, Tebatso Boshomane, Nozipho E. Nyakale, Mariza Vorster, Gbenga O. Popoola, Florette Reyneke, Ismaheel O. Lawal, Mike Sathekge
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Adult
Male
Oncology
medicine.medical_specialty
DOXORUBICIN
IMPACT
Dacarbazine
Standardized uptake value
Bleomycin
Risk Assessment
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Fluorodeoxyglucose F18
Internal medicine
medicine
Humans
Radiology
Nuclear Medicine and imaging

030212 general & internal medicine
VINBLASTINE
Extranodal Involvement
DACARBAZINE
ACTIVE ANTIRETROVIRAL THERAPY
Cluster of differentiation
business.industry
EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY
HIV
ADVANCED-STAGE
General Medicine
BLEOMYCIN
Prognosis
Hodgkin Disease
FDG PET/CT
Vinblastine
chemistry
TUMOR VOLUME
Positron-Emission Tomography
030220 oncology & carcinogenesis
International Prognostic Score
total lesion glycolysis
Female
maximum standardized uptake value
Risk assessment
business
Viral load
mean standardized uptake value
Hodgkin lymphoma
medicine.drug
metabolic tumor volume
Zdroj: Nuclear Medicine Communications, 39(11), 1005-1012. LIPPINCOTT WILLIAMS & WILKINS
ISSN: 0143-3636
Popis: Objectives Baseline metabolic metrics on fluorine-18-fluorodeoxyglucose PET (F-18-FDG PET) have prognostic value in Hodgkin lymphoma. International Prognostic Score (IPS) is used in the risk stratification of Hodgkin lymphoma. We compared the metabolic indices in HIV-infected and the IPS in HIV-infected and uninfected patients with Hodgkin lymphoma.Patients and methods We retrospectively reviewed the data of HIV-infected and HIV-uninfected patients with classic Hodgkin lymphoma who had F-18-FDG PET for staging and compared the maximum standardized uptake value, mean standardized uptake value, metabolic tumor volume, and total lesion glycolysis between the two groups. We also compared the IPS and other prognostic indicators and correlated them with the metabolic indices in the two groups.Results We studied 160 patients, which included 57 patients who were infected with HIV. The mean age was 33.84 +/- 11.88 years, with 38% (n = 61) being female. The median cluster of differentiation 4 count and HIV viral load were 259 cells/mm(3) and 4837.50 copies/ml, respectively. No significant difference in maximum standardized uptake value, mean standardized uptake value, metabolic tumor volume, and total lesion glycolysis between the two groups was found. Among the seven parameters of the IPS, only male sex (HIV-uninfected group higher, P = 0.005) and serum albumin less than 4 g/dl were significantly different. The other parameters were not significantly different between the two groups. Other prognostic indicators including bulky disease, extranodal involvement, and the number of nodal groups involved were not significantly different between the two groups.Conclusion There was no significant difference in F-18-FDG metabolic parameters, IPS, and other risk indicators between HIV-infected and HIV-uninfected patients with Hodgkin lymphoma. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.
Databáze: OpenAIRE